Literature DB >> 28476480

Mortality in patients resuscitated from out-of-hospital cardiac arrest based on automated blood cell count and neutrophil lymphocyte ratio at admission.

Christoph Weiser1, Michael Schwameis2, Fritz Sterz2, Harald Herkner2, Irene M Lang3, Ilse Schwarzinger4, Alexander O Spiel2.   

Abstract

INTRODUCTION: The neutrophil lymphocyte ratio(NLR) is a marker of systemic inflammation. We hypothesized that admission NLR is related to mortality and that epinephrine application during resuscitation influences NLR in patients after successful resuscitation from out of hospital cardiac arrest (OHCA).
METHODS: This retrospective cohort study is based on a registry including all OHCA patients who had a presumed cardiac cause of cardiac arrest and achieved sustained ROSC prior to admission between 2005 and 2014. Patients were categorized into three groups according to the calculated NLR at admission (NLR <6, ≥6, and 'abnormal differential' indicating no differential blood cell count on patients report due to exceedance of machine predefined parameter limits). The primary outcome measure was long-term mortality after OHCA. Cox proportional hazards models were used for multivariable analysis.
RESULTS: Out of 2273 OHCA patients during the study period a total of 1188(52%) patients were eligible for analysis, of those 274(23%) were female and mean age was 64 (25-75 IQR:52-72). Compared to a NLR<6 (n=442), adjusted hazard ratio for long-term mortality was significantly higher in patients with a NLR≥6 (n=447; 1.52 (95%CI 1.03-2.24)) and in patients with abnormal differential (n=299; 3.16 (95%CI 2.02-4.97)). Epinephrine application during resuscitation did not explain the effect of NLR on mortality.
CONCLUSION: In this large retrospective cohort study of altogether >1000 OHCA patients, hospital admission NLR<6 compared to abnormal differential or NLR≥6 was associated with mortality independently from epinephrine application.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epinephrine; Ischemia reperfusion injury; Neutrophil lymphocyte ratio; Out of hospital cardiac arrest; Post cardiac arrest syndrome; Prognostication

Mesh:

Substances:

Year:  2017        PMID: 28476480     DOI: 10.1016/j.resuscitation.2017.05.006

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  11 in total

1.  Clinical and Hematological Predictors for Return of Spontaneous Circulation in Patients With Out-of-Hospital Cardiac Arrest.

Authors:  Chih-Jung Chang; Tse-Hsuan Liou; Wei-Ting Tsai; Ching-Fang Hsu; Wah-Sheng Chong; Jen-Tang Sun; Tzung-Hai Yen; Wen-Chu Chiang; Chih-Chun Chang
Journal:  J Acute Med       Date:  2020-06-01

2.  Long-term Survival After Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-analysis.

Authors:  Simon A Amacher; Chantal Bohren; René Blatter; Christoph Becker; Katharina Beck; Jonas Mueller; Nina Loretz; Sebastian Gross; Kai Tisljar; Raoul Sutter; Christian Appenzeller-Herzog; Stephan Marsch; Sabina Hunziker
Journal:  JAMA Cardiol       Date:  2022-06-01       Impact factor: 30.154

3.  Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study.

Authors:  Anat Hershko Klement; Efrat Hadi; Aula Asali; Tal Shavit; Amir Wiser; Einat Haikin; Yael Barkan; Tal Biron-Shental; Alona Zer; Yifat Gadot
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

4.  Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest.

Authors:  Nina Buchtele; Christian Schörgenhofer; Alexander O Spiel; Bernd Jilma; Michael Schwameis
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

5.  Association between lymphocyte count and neurological outcomes in post-cardiac arrest patients treated with mild therapeutic hypothermia.

Authors:  Hidemitsu Miyatake; Kazunori Fujino; Sachiko Tanaka; Yasuyuki Tsujita; Minoru Horie; Yutaka Eguchi
Journal:  Acute Med Surg       Date:  2018-10-04

6.  Number of Circulating CD 73-Expressing Lymphocytes Correlates With Survival After Cardiac Arrest.

Authors:  Sergey Ryzhov; Teresa May; John Dziodzio; Ivette F Emery; F L Lucas; Angela Leclerc; Barbara McCrum; Christine Lord; Ashley Eldridge; Michel P Robich; Fumito Ichinose; Douglas B Sawyer; Richard Riker; David B Seder
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

7.  Gamma-Glutamyl Transpeptidase to Platelet Ratio: A New Inflammatory Marker Associated with Outcomes after Cardiac Arrest.

Authors:  Yipin Zhao; Zebin Lin; Yingying Ji; Huawei Wang; Li Xiao; Qingwei Chen; Zhiqin Wu
Journal:  Mediators Inflamm       Date:  2021-08-13       Impact factor: 4.711

8.  The association of early diarrhea after successful resuscitation following out-of-hospital cardiac arrest with neurological outcome: A retrospective observational study.

Authors:  Christoph Schriefl; Philipp Steininger; Christian Clodi; Matthias Mueller; Michael Poppe; Florian Ettl; Alexander Nuernberger; Juergen Grafeneder; Heidrun Losert; Michael Schwameis; Michael Holzer; Fritz Sterz; Christian Schoergenhofer
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

9.  Change of Hemoglobin Levels in the Early Post-cardiac Arrest Phase Is Associated With Outcome.

Authors:  Christoph Schriefl; Christian Schoergenhofer; Florian Ettl; Michael Poppe; Christian Clodi; Matthias Mueller; Juergen Grafeneder; Bernd Jilma; Ingrid Anna Maria Magnet; Nina Buchtele; Magdalena Sophie Boegl; Michael Holzer; Fritz Sterz; Michael Schwameis
Journal:  Front Med (Lausanne)       Date:  2021-06-09

10.  Increased Citrullinated Histone H3 Levels in the Early Post-Resuscitative Period Are Associated with Poor Neurologic Function in Cardiac Arrest Survivors-A Prospective Observational Study.

Authors:  Lisa-Marie Mauracher; Nina Buchtele; Christian Schörgenhofer; Christoph Weiser; Harald Herkner; Anne Merrelaar; Alexander O Spiel; Lena Hell; Cihan Ay; Ingrid Pabinger; Bernd Jilma; Michael Schwameis
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.